About Pemphigus

Overview

Pemphigus is an autoimmune disease that causes severe blistering of the skin and mucous membranes of the mouth, nose, throat, eyes, and genitals. It is characterized by a loss of cell-cell adhesion, leading to the formation of blisters. Pemphigus can affect people of all sexes equally and typically begins between the ages of 40 and 60.

There are several types of pemphigus, including:

• Pemphigus vulgaris: This is the most common type of pemphigus. Pemphigus vulgaris blisters are usually painful. It often first appears in the mouth and may spread to the skin and genitals. It accounts for about 70% of all pemphigus cases worldwide.
• Pemphigus foliaceus: This type of pemphigus usually causes blisters on the scalp, face, chest, and back. It is typically mild and not painful.
• Pemphigus vegetans: This type causes blisters in the groin, underarm area, and scalp.
• IgA pemphigus: This rare type of pemphigus causes rings of blisters or bumps resembling pimples on the skin.
• Paraneoplastic pemphigus: This rare type of pemphigus is associated with certain cancers, including some lymphomas. Blisters form in the mouth and may spread to the respiratory tract, including the lungs.

Medications may be used to help clear blisters and prevent new outbreaks of blisters. There current is no cure for pemphigus.

Causes and Risk Factors

Pemphigus is a condition where the immune system mistakenly attacks healthy skin cells, leading to blistering and sores on the skin and mucous membranes. The exact cause of pemphigus is not fully understood, but it is believed that an environmental factor triggers the body’s immune system to malfunctions and attacks the body's own tissues.

Non-modifiable risk factors for pemphigus include factors that cannot be changed or controlled by individuals. These include:

• Genetic predispositions: Pemphigus is not an inherited disease; however, family history of autoimmune diseases may increase the risk of pemphigus.
• Ethnic background: People of Jewish (especially Ashkenazi), Indian, Middle Eastern, and Southeast European descent have a higher risk of pemphigus. Pemphigus, however, may develop in people of all ethnicities and races.
• Sex: Pemphigus affects women more than men.
• Age: Pemphigus most often develops in people aged 50-60 years; however, it may develop in children.

Modifiable risk factors are factors a person can potentially change or control. Modifiable risk factors for pemphigus include:

• Stress, which may trigger episodes of pemphigus.
• Certain medications that can trigger or worsen autoimmune responses.
• Environmental factors that may influence the immune system's function.

Symptoms

The main symptoms of pemphigus include blistering of the skin and mucosal surfaces like the mouth, nose, throat, eyes, and genitals.

• These blisters can burst, leading to crusty sores that may become infected.
• In later stages or with higher severity of pemphigus, symptoms may involve more areas of the body.
  • In pemphigus vulgaris, blisters often start in the mouth and can progress to affect the skin. The skin may become very fragile and peel off easily.
  • In pemphigus foliaceus, blisters typically appear on the face, scalp, chest, or upper back initially and may spread to other skin areas. These blisters can grow in size and number over time and may cover large areas of the body like the torso, face, and scalp. The blisters break open easily and can ooze fluid. Rubbing the skin can cause the top layer to peel off entirely.
• Sores from blisters may crust over and scale.
• Pemphigus vulgaris is usually painful. While pemphigus foliaceus is usually not painful, some individuals may experience pain or a burning sensation. Itching in the blistered areas is also common in some cases.

Diagnosis

To diagnose pemphigus, doctors commonly perform the following examinations, tests, and procedures:

• Physical examination: The healthcare provider will examine the appearance and location of the blisters.
• Biopsy: A small sample of tissue is taken from a blister for microscopic examination to confirm the diagnosis.
• Chemical biopsy: Chemicals are applied to the skin to determine the specific type of pemphigus causing the blisters.
• Blood work: Blood samples are taken to measure levels of pemphigus antibodies in the blood.

Additional examinations, tests, and procedures may include:

• Direct immunopathological examination: This involves examining a skin section using direct immunofluorescence (DIF) to detect autoantibody deposits in the skin.
• Indirect immunofluorescence: Testing the patient's serum for specific antibodies using indirect immunofluorescence (IIF).
• Immunoenzymatic methods: These include enzyme-linked immunosorbent assay (ELISA), immunoblot (IB), and immunoprecipitation (IP) to detect autoantibodies.
• Routine histopathological examination: This helps differentiate pemphigus from other blistering skin diseases by looking for specific features like acantholysis and neutrophilic infiltrates.

Treatment Options

The goals of treating pemphigus are to clear existing blisters, prevent relapses, and maintain remission, which means being lesion-free.

• Medications used in pemphigus treatment include:
  • Corticosteroids, which reduce inflammation and can be applied topically or taken orally.
  • Immunosuppressants to calm the overactive immune system.
  • Biologic response modifiers that target specific immune signals to stop skin attacks.
  • Antibiotics, antivirals, and antifungal medications may be used to manage or prevent infections that can occur due to the disease or its treatment.
• Therapeutic procedures may involve:
  • Plasmapheresis or immunoadsorption to remove harmful antibodies from the blood.
  • Intravenous immunoglobulin therapy to provide healthy antibodies from donors.
• Self-care and health behavior changes:
  • Schedule regular visits with the dentist. More frequent dental cleanings may be needed because blisters in the mouth may make brushing and flossing painful.
  • Eat soft foods to avoid irritating blisters in the mouth.
  • Follow the advice of the dermatologist or other healthcare provider about bathing with blisters and how to care for skin sores while they heal.

In severe cases, hospitalization may be required to address complications like dehydration, infections, and other health problems associated with pemphigus. Intravenous fluids, nutrition support, and infection treatment may be necessary during hospital stays.

It is important to note that treatment plans may vary based on individual patient characteristics and disease severity. Consultation with a healthcare professional is essential to determine the most appropriate treatment approach for each individual. Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for side effect information.

Progression or Complications

Pemphigus is a rare autoimmune disease that causes blistering of the skin and mucous membranes. The disease can progress over time, leading to the formation of blisters on the skin and mucous membranes. These blisters can be painful and may increase in number and severity if left untreated. Without proper medical intervention, it can be fatal.

Common complications of pemphigus include:

• Infections.
• Dehydration.
• Difficulty eating due to painful blisters in the mouth.

The impact of treatment is significant in controlling the disease, clearing existing blisters, and helping prevent relapses. However, most people with pemphigus need to continue taking medications long-term to keep the disease under control.